3,109
Participants
Start Date
October 1, 2010
Primary Completion Date
July 1, 2011
Study Completion Date
July 1, 2011
Quadrivalent seasonal influenza vaccine GSK2282512A
For subject 3 to 8 years of age, single intramuscular dose for primed subjects, two doses for unprimed subjects. For subjects 9 to 17 years of age, single intramuscular dose.
Fluarix™ VB
For subject 3 to 8 years of age, single intramuscular dose for primed subjects, two doses for unprimed subjects. For subjects of 9 to 17 years of age, single intramuscular dose.
Fluarix™ YB
For subject 3 to 8 years of age, single intramuscular dose for primed subjects, two doses for unprimed subjects. For subjects of 9 to 17 years of age, single intramuscular dose
Quadrivalent seasonal influenza vaccine GSK2282512A
Single intramuscular dose for primed subjects, two doses for unprimed subjects.
GSK Investigational Site, Taipei
GSK Investigational Site, Taichung
GSK Investigational Site, Hermitage
GSK Investigational Site, Madrid
GSK Investigational Site, Pozuelo de Alarcón/Madrid
GSK Investigational Site, Barnwell
GSK Investigational Site, Clarksville
GSK Investigational Site, Seville
GSK Investigational Site, Alcalá de Guadaira
GSK Investigational Site, Niles
GSK Investigational Site, St Louis
GSK Investigational Site, Monterrey
GSK Investigational Site, Omaha
GSK Investigational Site, Little Rock
GSK Investigational Site, Harrisburg
GSK Investigational Site, Fort Worth
GSK Investigational Site, Centennial
GSK Investigational Site, Thornton
GSK Investigational Site, Longmont
GSK Investigational Site, Chandler
GSK Investigational Site, Scottsdale
GSK Investigational Site, Paramount
GSK Investigational Site, Huntington Beach
GSK Investigational Site, Edmonton
GSK Investigational Site, Surrey
GSK Investigational Site, Winnipeg
GSK Investigational Site, Mount Pearl
GSK Investigational Site, Halifax
GSK Investigational Site, Brampton
GSK Investigational Site, Greater Sudbury
GSK Investigational Site, Hamilton
GSK Investigational Site, Saskatoon
GSK Investigational Site, Mexico City
Lead Sponsor
GlaxoSmithKline
INDUSTRY